We’d love to hear your feedback on this activity. It helps us to continually improve our products.
Please provide feedback for this on the following(scale 1-5, 1 strongly disagree; 5 strongly agree):
* = Mandatory Field
World Tuberculosis (TB) Day is observed annually on 24 March to raise awareness about tuberculosis and to commemorate the discovery of the Mycobacterium tuberculosis bacterium (M.tb) by Dr Robert Koch in 1882. It aims to educate people about the impact of TB on public health, and encourage governments and organizations to take action towards ending the TB […]
Rare diseases can present numerous challenges for those living with these conditions and the healthcare professionals caring for them. In this interview we discuss some of these with Lisa Sarfaty, VP of Communication and Engagement for NORD (The National Organization for Rare Disorders) and explore ways in which they could be tackled. Questions Could you […]
Our society partner, NORD (The National Organization for Rare Disorder) has planned several initiatives to support this year’s Rare Disease Day on 28 February. These activities are aimed at raising awareness about rare diseases and the challenges faced by people living with these conditions. In this video, Lisa Sarfaty, NORD’s VP of Communication and Engagement, […]
INCREASE OLE was the open-label extension of the INCREASE study (NCT02630316), which investigated the safety and efficacy of inhaled treprostinil in patients with pulmonary hypertension due to interstitial lung disease. We caught up with Prof. Jean Elwing (UC Health, Cincinnati, OH, USA) to discuss the methodology, inclusion criteria, and safety and tolerability findings from the […]
BEAT tuberculosis (NCT04062201) investigated treatment with a short course of a delamanid-bedaquiline regimen for rifampicin resistant tuberculosis (RR-TB) in South Africa. It was a pleasure to talk with Dr Francesca Conradie (University of the Witwatersrand, Johannesburg, South Africa) around the aims and design of the BEAT tuberculosis study and the findings from the interim analysis. […]
Point-of-care ultrasound (POCUS) is a potential triage tool for tuberculosis (TB) that could allow non-specialist healthcare workers to guide decision-making in TB management. In this touchRESPIRATORY interview, we speak with Dr. Veronique Suttels (Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland) to discuss the intermediate analysis of the study investigating POCUS in Benin and the potential impact […]
Pulmonary tuberculosis (TB) is a contagious infectious disease caused by Mycobacterium tuberculosis, symptoms can include a cough, chest pain and breathlessness, and in some cases the infection can spread to other organs. In this touchRESPIRATORY interview, we speak with Dr. Veronique Suttels (Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland) to discuss the strengths and limitations of […]
Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that remains highly undiagnosed. It is estimated that between 1 to 5% of patients with chronic obstructive pulmonary disease (COPD) have AATD; however is often not diagnosed. We caught up with Prof. Charlie Strange (MUSC, Charleston, SC, USA) to discuss what methods are currently available for the […]
Longitudinal studies into the long-term impact of COVID-19 are currently at the forefront of research, touchRESPIRATORY interviewed editorial board member Prof. Margaret Pisani (Yale School of Medicine. New Haven, CT, USA) about what to look out for in 2023 in this area. Disclosures: Margaret Pisani has nothing to disclose in relation to this video interview. Support: Interview and filming […]
Get the latest clinical insights from touchRESPIRATORY